Search results for “Cell cancer” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 106 patents, we discovered top 75 key players by total patent application. Eli Lilly & Co., Andes Biotechnologies SA, TransMolecular, Inc. are dominant in this area. They take 11.32% of the total patent filing.
Eli Lilly & Co.
Indiana, United States
Patent: 4
Andes Biotechnologies SA
Chile
Patent: 4
TransMolecular, Inc.
Alabama, United States
Patent: 4
Genentech, Inc.
California, United States
Patent: 3
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 3
Novartis AG
Basel-Stadt, Switzerland
Patent: 2
Takeda Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 2
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 2
OncoTherapy Science, Inc.
Kanagawa-ken, Japan
Patent: 2
Taiho Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 11 patents applied in the last 5 years. We discover 9 most active companies in this area. The fast-growing Hebei Normal University, Beijing Hongsheng InnoLight Biotechnology Co., Ltd., Soochow University take 27.27% of patent filing during this period.
Hebei Normal University
Hebei Sheng, China
Patent: 1
Beijing Hongsheng InnoLight Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 1
Soochow University
Jiangsu Sheng, China
Patent: 1
West China Second University Hospital
China
Patent: 1
Immunomedics, Inc.
New Jersey, United States
Patent: 1
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 1
Guangzhou University of Chinese Medicine
Guangdong Sheng, China
Patent: 1
Lunella Biotech Inc
United States
Patent: 1
Chengdu Genomeer Biotechnology Co., Ltd.
Sichuan Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 11 patents in last 5 years, we discover 8 new entrants. Hebei Normal University, Beijing Hongsheng InnoLight Biotechnology Co., Ltd., Soochow University are the most active new entrants in this area.
Hebei Normal University
Hebei Sheng, China
Patent: 1
Beijing Hongsheng InnoLight Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 1
Soochow University
Jiangsu Sheng, China
Patent: 1
West China Second University Hospital
China
Patent: 1
Immunomedics, Inc.
New Jersey, United States
Patent: 1
Guangzhou University of Chinese Medicine
Guangdong Sheng, China
Patent: 1
Lunella Biotech Inc
United States
Patent: 1
Chengdu Genomeer Biotechnology Co., Ltd.
Sichuan Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 71 patents, we discovered top 20 universities and scientific research institutions by total patent application. The Trustees of Columbia University in The City of New York, Institut Gustave Roussy EURL, The Second Military Medical University are dominant in this area. They take 16.90% of the total patent filing.
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 5
Institut Gustave Roussy EURL
France
Patent: 4
The Second Military Medical University
Shanghai Shi, China
Patent: 3
Duke University
North Carolina, United States
Patent: 2
Boston University
Massachusetts, United States
Patent: 2
University of Windsor
Ontario, Canada
Patent: 2
Kinki University
Osaka-fu, Japan
Patent: 2
Rosalind Franklin University of Medicine & Science
Illinois, United States
Patent: 2
Kumamoto University
Kumamoto-ken, Japan
Patent: 2
University of Zurich
ZURICH, Switzerland
Patent: 2
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: